This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp + Dohme B.v., Merck Sharp + Dohme Corp.. Active years: 2021.
Company Filing History:
1 out of 55 
1 out of 2,405 
Years Active: 2021
Title: The Innovative Contributions of Amitava Mitra
Introduction
Amitava Mitra is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on developing formulations for parenteral administration, particularly in the treatment of HIV and AIDS.
Latest Patents
Mitra holds a patent for a formulation designed for parenteral administration. This innovative drug product comprises a suspension of doravirine, which can be administered via intramuscular or subcutaneous routes. The formulation is intended for the treatment or prophylaxis of HIV infection and aims to delay the onset of AIDS or AIDS-related complex (ARC). He has 1 patent to his name.
Career Highlights
Throughout his career, Amitava Mitra has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Merck Sharp & Dohme B.V. His experience in these organizations has allowed him to contribute to the development of critical healthcare solutions.
Collaborations
Mitra has collaborated with talented professionals in his field, including Sachin Mittal and Irina Kazakevich. These partnerships have further enhanced his innovative capabilities and have led to advancements in pharmaceutical formulations.
Conclusion
Amitava Mitra's contributions to pharmaceutical innovations, particularly in the area of HIV treatment, highlight his role as a significant inventor. His work continues to impact the healthcare industry positively.